Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07190482
PHASE1

Treatment of Tinnitus With Olanzapine

Sponsor: University of Sao Paulo

View on ClinicalTrials.gov

Summary

This research aims to evaluate the effects of the drug olanzapine on the discomfort caused by tinnitus according to each patient's personality traits. Olanzapine is a drug used as an antipsychotic whose mechanism of action makes it potentially useful for the treatment of tinnitus.

Official title: Treatment of Tinnitus With Olanzapine: A Randomized Crossover Versus Placebo Study

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2023-10-01

Completion Date

2025-01-20

Last Updated

2026-09-15

Healthy Volunteers

No

Interventions

DRUG

Olanzapine 5 Mg ORAL TABLET

OLANZAPINE ARM

DRUG

Placebo Drug

placebo administered for 8 weeks

Locations (1)

Research Ethics Committee (CEP)

São Paulo, São Paulo, Brazil